In conclusion, the results suggest that either a GABACR antagonist or a mGluR1 antagonist may improve contrast sensitivity in patients with retinitis pigmentosa and possibly other retinal diseases in which there is photoreceptor degeneration with concomitant remodeling of cells within the inner retina. The gene discussed is GRM1; the disease is retinitis pigmentosa.